Application of exocarpium citri rubrum expectoration extract in preparation of medicine for inhibiting human coronavirus infection

A technology of human coronavirus, orange-red phlegm cough, applied in the field of medicine

Pending Publication Date: 2021-09-17
GUANGZHOU XINGQUN PHARMA
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prevention and treatment effect of Juhong Tanke Recipe on human coronavirus infection has not been reported before.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of exocarpium citri rubrum expectoration extract in preparation of medicine for inhibiting human coronavirus infection
  • Application of exocarpium citri rubrum expectoration extract in preparation of medicine for inhibiting human coronavirus infection
  • Application of exocarpium citri rubrum expectoration extract in preparation of medicine for inhibiting human coronavirus infection

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0027] The preparation method of the orange-red phlegm and cough extract is as follows: distill the orange-red and bitter almonds with water vapor, and collect the distillate; mix the dregs with Mibabu, Poria cocos, Shui Pinellia (manufactured), Baiqian, licorice and Schisandra chinensis Mix, respectively add (the total weight of the dregs and honey baebu, Poria cocos, Shui Pinellia (made), Baiqian, licorice and Schisandra chinensis) 6-8 times the amount of water, 4-6 times the amount of water to decoct twice, filter After that, combine the filtrate and distillate, concentrate to a relative density of 1.05-1.25 (80°C), add ethanol to make the alcohol content reach 75-80%, let it stand for 18-24 hours, take the supernatant, and concentrate to a relative density 1.05-1.25 (80°C), the orange red phlegm and cough extract is obtained.

[0028] HuH-7 cells were purchased from the Virus Laboratory of the State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory...

Embodiment 1

[0030] Embodiment 1 cytotoxicity test (MTT method)

[0031] (1) Test drugs: as shown in Table 1;

[0032] Table 1 Drug name, experimental concentration and grouping

[0033]

[0034] (2) In a sterile 96-well culture plate, add 100 μL to each well with a concentration of 2×10 5 cells / mL Huh-7 cells, 37℃5%CO 2 Cultivate for 24 hours;

[0035] (3) The monolayer cells of the 96-well plate were washed once with PBS, and 100 μL of 2-fold serially diluted drug was added to each well. Add an equal volume of 2% serum medium to each well of the blank control group and normal cell group, and culture at 37°C for 4 days;

[0036] (4) Add 20 μL of MTT solution with a concentration of 5 mg / mL to each well and continue to incubate for 4 hours. Discard the supernatant, add 100 μL DMSO to each well, and shake at low speed for 5 minutes to fully melt the crystals;

[0037] (5) Select a wavelength of 490nm, measure the absorbance on an enzyme-linked immunosorbent analyzer, and calculate th...

Embodiment 2

[0040] Embodiment 2 test drug antiviral experiment

[0041] (1) Test drugs: as shown in Table 2

[0042] Table 2 Drug name, experimental concentration and grouping

[0043]

[0044] (2) In a sterile 96-well culture plate, add 100 μL to each well with a concentration of 2×10 5 cells / mL Huh-7 cells, 37℃5%CO 2 Cultivate for 24 hours;

[0045] (3) Add 100TCID to the culture plate experimental group and the virus control group 50 Virus solution 100 μL / well, 37°C 5% CO 2 Adsorption in the incubator for 2h;

[0046] (4) After 2 hours, the cell culture solution in the 96-well culture plate was discarded; the test drug was diluted to each concentration in Table 2, and each concentration was repeated in 3 wells, and 100 μl / well of the above drug solution was added;

[0047] (5) Set up cell control and virus control (negative control) at the same time;

[0048] (6) cells at 37°C, 5% CO 2 Incubate in the incubator for 3-4 days;

[0049] (7) Observing cytopathic changes (CPE) u...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of medicines, and particularly relates to application of exocarpium citri rubrum expectoration extract in preparation of a medicine for inhibiting human coronavirus infection. The invention provides application of exocarpium citri rubrum expectoration extract in preparation of the medicine for inhibiting human coronavirus infection, and experiments show that the exocarpium citri rubrum expectoration extract can inhibit mRNA overexpression of human coronavirus-induced inflammatory factors TNF-alpha, IL-6, IL-8 and IFN-alpha, so that the human coronavirus is inhibited.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a new application of medicine, in particular to the application of Juhongtanke extract in the preparation of medicines for inhibiting human coronavirus infection. Background technique [0002] Coronavirus (CoV) belongs to the order Coronaviridae, Coronaviridae, and the genus Coronaviridae. It is an enveloped positive-sense single-stranded RNA virus with a diameter of 80-120nm and about 30,000 bases. Its genetic material is Largest known RNA virus. The coronavirus consists of a nucleocapsid protein (N protein), a spike glycoprotein (S protein) at the receptor binding site, a small envelope glycoprotein (E protein), a membrane glycoprotein (M protein) responsible for transporting nutrients, Hemagglutinin glycoprotein (HE protein) and ribonucleic acid (RNA) composition. In 2012, the International Virus Classification and Nomenclature Committee classified coronaviruses into four grou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/904A61K9/06A61P11/00A61P31/14
CPCA61K36/752A61K36/904A61K36/076A61K36/8888A61K36/27A61K36/484A61K36/736A61K36/79A61K36/57A61K9/06A61P11/00A61P31/14A61K2236/331A61K2236/55A61K2300/00Y02A50/30
Inventor 孙维广高建胜万安凤钟小天杜曼玲黄志云
Owner GUANGZHOU XINGQUN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products